<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00407992</url>
  </required_header>
  <id_info>
    <org_study_id>MFGGL113006</org_study_id>
    <nct_id>NCT00407992</nct_id>
  </id_info>
  <brief_title>An Italian Randomized Open-label Study of Occipital Nerve Stimulation in the Treatment of Chronic Migraine Headache</brief_title>
  <acronym>Migraine</acronym>
  <official_title>An Italian, Randomized, Single-centre, Open-label Study of Occipital Nerve Stimulation in the Treatment of Chronic Migraine Headache</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>IRCCS Sacro Cuore Don Calabria di Negrar</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>IRCCS Sacro Cuore Don Calabria di Negrar</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the safety and the efficacy of occipital nerve
      stimulation treating Chronic Migraine Headache
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2006</start_date>
  <completion_date type="Actual">December 2010</completion_date>
  <primary_completion_date type="Actual">December 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number and the type of adverse events</measure>
    <time_frame>Study period</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Reduction of headache frequency and intensity</measure>
    <time_frame>Study period</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Reduction in drug intake</measure>
    <time_frame>Study period</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in QoL and interference in everyday activities</measure>
    <time_frame>Study period</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">34</enrollment>
  <condition>Headache, Migraine</condition>
  <arm_group>
    <arm_group_label>Occipital nerve stimulation ON</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Occipital nerve stimulation OFF</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Occipital nerve stimulation ON</intervention_name>
    <description>Implant of an occipital nerve stimulator switched ON</description>
    <arm_group_label>Occipital nerve stimulation ON</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Occipital nerve stimulation off</intervention_name>
    <description>Implant of an occipital nerve stimulator switched OFF</description>
    <arm_group_label>Occipital nerve stimulation OFF</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with migraine

          -  patients 18 years aged or above

        Exclusion Criteria:

          -  patients which participated within the last 30 days or plan to participate during this
             study in another device or drug trial

          -  patients pregnant or planning on becoming pregnant during the study period
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gerardo Serra</last_name>
    <role>Principal Investigator</role>
    <affiliation>IRCCS Sacro Cuore Don Calabria di Negrar</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ospedale Sacro Cuore - Don Calabria</name>
      <address>
        <city>Negrar</city>
        <state>Verona</state>
        <zip>37024</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <results_reference>
    <citation>Serra G, Marchioretto F. Occipital nerve stimulation for chronic migraine: a randomized trial. Pain Physician. 2012 May-Jun;15(3):245-53.</citation>
    <PMID>22622909</PMID>
  </results_reference>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>December 4, 2006</study_first_submitted>
  <study_first_submitted_qc>December 4, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 5, 2006</study_first_posted>
  <last_update_submitted>September 19, 2019</last_update_submitted>
  <last_update_submitted_qc>September 19, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 23, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Headache</keyword>
  <keyword>Migraine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Migraine Disorders</mesh_term>
    <mesh_term>Headache</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

